Conditions: Inflammation Pain Cataract
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 177
Healthy volunteers: no

Brief summary:
The objective of this study is to compare the safety and efficacy of Mapracorat Ophthalmic Suspension, 3% to vehicle for the treatment of postoperative inflammation and pain following cataract surgery.

Detailed description:

Arms:
arm 1: Mapracorat ophthalmic suspension arm 2: Vehicle of mapracorat ophthalmic suspension

Interventions: intervention 1: Mapracorat intervention 2: Vehicle
Intervention descriptions: intervention 1: Mapracorat ophthalmic suspension 3%, one drop in post-operative study eye once daily (QD) for 2 weeks. intervention 2: Vehicle of mapracorat ophthalmic suspension, one drop in post-operative study eye once daily (QD) for 2 weeks.

Protocol document: